1. Home
  2. KALA vs CGTL Comparison

KALA vs CGTL Comparison

Compare KALA & CGTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • CGTL
  • Stock Information
  • Founded
  • KALA 2009
  • CGTL 2016
  • Country
  • KALA United States
  • CGTL Hong Kong
  • Employees
  • KALA N/A
  • CGTL N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • CGTL
  • Sector
  • KALA Health Care
  • CGTL
  • Exchange
  • KALA Nasdaq
  • CGTL NYSE
  • Market Cap
  • KALA 26.2M
  • CGTL 22.1M
  • IPO Year
  • KALA 2017
  • CGTL 2024
  • Fundamental
  • Price
  • KALA $4.03
  • CGTL $1.45
  • Analyst Decision
  • KALA Strong Buy
  • CGTL
  • Analyst Count
  • KALA 3
  • CGTL 0
  • Target Price
  • KALA $14.00
  • CGTL N/A
  • AVG Volume (30 Days)
  • KALA 38.5K
  • CGTL 7.6M
  • Earning Date
  • KALA 08-05-2025
  • CGTL 08-15-2025
  • Dividend Yield
  • KALA N/A
  • CGTL N/A
  • EPS Growth
  • KALA N/A
  • CGTL 35.72
  • EPS
  • KALA N/A
  • CGTL 0.21
  • Revenue
  • KALA N/A
  • CGTL $35,611,761.00
  • Revenue This Year
  • KALA N/A
  • CGTL N/A
  • Revenue Next Year
  • KALA N/A
  • CGTL N/A
  • P/E Ratio
  • KALA N/A
  • CGTL $6.77
  • Revenue Growth
  • KALA N/A
  • CGTL N/A
  • 52 Week Low
  • KALA $2.92
  • CGTL $0.81
  • 52 Week High
  • KALA $11.20
  • CGTL $10.59
  • Technical
  • Relative Strength Index (RSI)
  • KALA 53.41
  • CGTL N/A
  • Support Level
  • KALA $4.10
  • CGTL N/A
  • Resistance Level
  • KALA $4.41
  • CGTL N/A
  • Average True Range (ATR)
  • KALA 0.39
  • CGTL 0.00
  • MACD
  • KALA 0.01
  • CGTL 0.00
  • Stochastic Oscillator
  • KALA 52.39
  • CGTL 0.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED

Creative Global Technology Holdings Ltd conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.

Share on Social Networks: